Skip to content
Screener

uniQure QURE Hemgenix — Other Expenses

Similar metrics at other companies

Vail Resorts logo
MTNLodging Operating Expense — Other Expenses
$20.92M+5.2%
Vail Resorts logo
MTNMountain Operating Expense — Other Expenses
$137.6M-4.7%
Lithium Americas logo
LACConstruction — Other Expenses
$3.53M
Vail Resorts logo
MTNReal Estate Operating Expense — Other Expenses
$1.48M-11.3%
Cognex logo
CGNXSegment, General, And Engineering Expense — Other Expenses
$21.75M+5.5%
Investors Title Company logo
ITICAll Other — Other Expenses
$1.33M-14.0%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.2B+312%
Enterprise value$2.84B+384%
P/S171.1×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OtherExpenses.

The source filing: uniQure’s 10-K, filed March 2, 2026.

Filed
Mar 2, 2026, 7:24 AM EST
Fiscal year
FY2025
Accession
0001104659-26-021898

In the years ended December 31, 2025 and 2024, the Company recognized $6.3 million and $3.2 million, respectively (nil in the period ended December 31, 2023) in Other expense related to the purchase of HEMGENIX from Genezen, net of income from the sales of HEMGENIX to CSL Behring, amortization of the intangible asset for the favorable supply terms under the CSA and credits from the release of liabilities related to expected net losses associated with the minimum purchase commitments under the CSA.

Item 16. Form 10-K Summary

FAQ

What is uniQure's hemgenix — other expenses?
uniQure (QURE) reported hemgenix — other expenses of $1.58M in Q4 2025.
How has uniQure's hemgenix — other expenses changed year-over-year?
uniQure's hemgenix — other expenses increased by 96.9% year-over-year, from $800K to $1.58M.
What does hemgenix — other expenses mean?
This metric captures ancillary operational costs specifically attributable to the Hemgenix product line that fall outside of standard direct manufacturing or research and development categories. These expenses typically include product-specific logistics, regulatory compliance fees, or specialized marketing and distribution support required for commercialization. Tracking these costs provides insight into the non-production overhead required to support the market presence and lifecycle management of the therapy.

Ask your AI about uniQure's hemgenix — other expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude